20 April 2007

Home

Products

Services

Contact Us

About SOLVO

BCRP-HAM FLYER


Meet SOLVO at the 3rd World Congress of the Board of Pharmaceutical Sciences of FIP (PSWC 2007) in Amsterdam!

We are looking forward to meeting you at our booth No. 81 in the RAI Congress Centre, during the 3rd World Congress of the Board of Pharmaceutical Sciences of FIP on 22-25 April 2007 in Amsterdam, The Netherlands!
The following posters will be presented during the congress:

1. Abstr. No. 1388: EXCIPIENTS MAY MODULATE THE PATHWAYS IN ADME/TOX VIA ABC-TRANSPORTERS
http://www.solvo.com/pdfs/Excipients_may_modulate_the_pathways_in_ADME_Tox.pdf


2. Abstr. No. 1354: NEW MAMMALIAN MIMIC MODEL MEMBRANE TO STUDY DRUG INTERACTIONS WITH HUMAN BCRP IN A HIGH
THROUGHPUT SCREENING MODEL
http://www.solvo.com/pdfs/New_mammalian_mimic_model_membrane.pdf

Come along and learn more about SOLVO: How our membrane transporter technologies can support your drug discovery and development efforts.

With our best regards,
SOLVO Biotechnology
Business Development Team



How to order:

For North American Customers (US & Canada):
XenoTech LLC www.xenotexhllc.com


For Customers in Japan:
Funakoshi www.funakoshi.co.jp, Iwaki www.iwaki-kk.co.jp and Nosan www.nosan.co.jp


For Customers in Europe and other countries:
SOLVO Biotechnology www.solvo.com
Fax: +36 23 503941
Email:

For Customers in Japan: Funakoshi (distributor of SOLVO membrane products) Iwaki (exclusive distributor of SOLVO Fee-for Service Screenings, distributor of SOLVO membrane products)
Privileged/confidential information may be contained in this message. This communication is confidential and intended solely for the addressee(s). Unauthorized distribution, modification or disclosure of the contents may be unlawful. If you receive this in error, please notify the sender and delete it from your system. If you are not the addressee indicated in this message (or responsible for delivery of the message to such person), you may not copy or deliver this message to anyone.
If you wish to unsubscribe, please send a letter to with 'unsubscribe' in the subject field.